November 28, 2015
Recommended Topic Related To:


"The US Food and Drug Administration (FDA) has approved a new inhaled combination bronchodilator for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), according to a company news "...



To assure the safe and effective use of Provocholine® (methacholine chloride) inhalation challenge, the following instructions and information should be given to patients:

Patients should be instructed regarding symptoms that may occur as a result of the test and how such symptoms can be managed.

A female patient should inform her physician if she is pregnant, or the date of her last onset of menses, or the date and result of her last pregnancy test. (See PRECAUTIONS: Pregnancy.)

Last reviewed on RxList: 9/25/2008
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.